Bank Of New York Mellon Corp Bicycle Therapeutics PLC Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$41.7 - $61.14 $354,033 - $519,078	-8,490 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$27.95 - $44.24 $101,458 - $160,591	-3,630 Reduced 29.95%	8,490 $353,000
Q2 2021 Aug 11, 2021	SELL	$27.0 - $32.28 $810 - $968	-30 Reduced 0.25%	12,120 $367,000
Q1 2021 May 13, 2021	SELL	$19.12 - $30.25 $21,414 - $33,880	-1,120 Reduced 8.44%	12,150 $362,000
Q4 2020 Feb 09, 2021	BUY	$17.95 - $21.36 $238,196 - $283,447	13,270 New	13,270 $238,000

111

40.7M

3.4K

12.4K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $757M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.